Description
5 mg | Bortezomib | Solución Inyectable | Frasco Ámpula | ULSA Tech México
PRINCIPIO ACTIVO: FILGRASTIM
No administrar dentro de las 14 horas previas a la quimioterapia
STELARA® 45 mg es un medicamento biológico que contiene Ustekinumab
PRINCIPIO ACTIVO: DOBESILAT DE CALCIO
SUEROX AD MANZANA 630ML COCAMYDE MEA 5 mg | Bortezomib |PRINCIPIO ACTIVO: ELECTROLITOS ORALES DOSIS: 630 ML FORMA FARMACUTICA: 1 SUERO ORAL PRESENTACIN: 1 BOTELLA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
























